CORC  > 中南大学
Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
Xiao, Yang; Liu, Lingjiao; Xu, Aimin; Zhou, Pengcheng; Long, Zhaofeng; Tu, Yiting; Chen, Xiaoyan; Tang, Weili; Huang, Gan; Zhou, Zhiguang*
刊名Cardiovascular Diabetology
2015
卷号14期号:1页码:72
关键词Fibroblast growth factor 21 Intima-media thickness Subclinical atherosclerosis Type 2 diabetes
ISSN号1475-2840
DOI10.1186/s12933-015-0229-9
URL标识查看原文
WOS记录号WOS:000356481300001
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3320215
专题中南大学
作者单位1.[Liu, Lingjiao
2.Chen, Xiaoyan
3.Zhou, Zhiguang
4.Tang, Weili
5.Tu, Yiting
6.Xiao, Yang
7.Huang, Gan] Cent S Univ, Key Lab Diabet Immunol, Natl Clin Res Ctr Metab Dis, Minist Educ,Xiangya Hosp 2,Diabet Ctr, Changsha, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Xiao, Yang,Liu, Lingjiao,Xu, Aimin,et al. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes[J]. Cardiovascular Diabetology,2015,14(1):72.
APA Xiao, Yang.,Liu, Lingjiao.,Xu, Aimin.,Zhou, Pengcheng.,Long, Zhaofeng.,...&Zhou, Zhiguang*.(2015).Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.Cardiovascular Diabetology,14(1),72.
MLA Xiao, Yang,et al."Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes".Cardiovascular Diabetology 14.1(2015):72.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace